You are using an outdated browser. Please upgrade your browser to improve your experience.

acitretin/etretinate embryopathy

Disease Summary
Associated Targets ()

Mondo Description Acitretin/Etretinate embryopathy is a teratogenic disorder due to acitretin or etretinate exposure during the first trimester of pregnancy, carrying a risk of fetal malformations of approximately 20%, including central nervous system, craniofacial, ear, thymic, cardiac and limb anomalies.
Mondo Term and Equivalent IDs
MONDO:0018442:  acitretin/etretinate embryopathy
GARD:0000468: 
MESH:C538169: 
Orphanet:40366: 
SCTID:725287006: 
UMLS:CN205049: